Star: KUALA LUMPUR: Some 230 advanced-stage lung cancer patients in the country will take part in clinical trials for a therapeutic cancer vaccine.
Deputy Health Minister Datuk Dr Abdul Latiff Ahmad said the vaccine, Epidermal Growth Factor (EGF), was the first of its kind in the world and produced here with the cooperation between Malaysia and Cuba.
“The second and third phases of the clinical trials would be conducted on 230 patients who volunteered to undertake the trials at 14 hospitals nationwide.
“They have been told they have about six months to live,” he told a press conference.
Dr Latiff said the trials would be conducted by a local biotechnology company and Cuban researchers.
Malaysian Medical News: keeping you up to date with news sourced from various online sites, put in one place for your convenience, with a searchable archive
No comments:
Post a Comment